Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$1.21B |
| 2 |
Sea Limited
SE
|
+$842M |
| 3 |
Okta
OKTA
|
+$819M |
| 4 |
XYZ
Block Inc
XYZ
|
+$749M |
| 5 |
Mercado Libre
MELI
|
+$656M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$929M |
| 2 |
Union Pacific
UNP
|
+$677M |
| 3 |
Spotify
SPOT
|
+$575M |
| 4 |
RingCentral
RNG
|
+$499M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.98% |
| 2 | Consumer Discretionary | 23.1% |
| 3 | Communication Services | 15.59% |
| 4 | Healthcare | 8.54% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
MetLife
MET
$61.9B
| $194M | 0.13% |
3,143,339
-51,786
| -2% | -$3.12M |
|
77
Walmart Inc
WMT
$885B
| $192M | 0.12% |
4,124,787
-216,426
| -5% | -$10.4M |
|
78
Crown Holdings
CCK
$12.8B
| $187M | 0.12% |
1,852,389
-17,097
| -0.9% | -$1.79M |
|
79
Broadcom
AVGO
$1.85T
| $185M | 0.12% |
3,824,570
-198,190
| -5% | -$9.64M |
|
80
AstraZeneca
AZN
$263B
| $183M | 0.12% |
1,524,409
-11
| -0% | -$1.28K |
|
81
General Motors
GM
$80.4B
| $176M | 0.11% |
3,346,688
-395,410
| -11% | -$21M |
|
82
Ameren
AEE
$30.3B
| $173M | 0.11% |
2,135,352
-56,303
| -3% | -$4.8M |
|
83
Abbott
ABT
$183B
| $172M | 0.11% |
1,459,984
-46,453
| -3% | -$5.71M |
|
84
Capital One
COF
$128B
| $168M | 0.11% |
1,038,810
+85,408
| +9% | +$13.9M |
|
85
Targa Resources
TRGP
$58B
| $167M | 0.11% |
3,385,310
-1,144,944
| -25% | -$50.4M |
|
86
Zimmer Biomet
ZBH
$18.2B
| $164M | 0.11% |
1,156,725
-215,987
| -16% | -$31.8M |
|
87
Williams Companies
WMB
$87.5B
| $158M | 0.1% |
6,074,410
-1,877,671
| -24% | -$47.3M |
|
88
Qualcomm
QCOM
$155B
| $154M | 0.1% |
1,191,185
+497,079
| +72% | +$70.5M |
|
89
CenterPoint Energy
CNP
$27.7B
| $153M | 0.1% |
6,233,087
-12,980
| -0.2% | -$332K |
|
90
Public Service Enterprise Group
PEG
$38.2B
| $151M | 0.1% |
2,482,113
+403,074
| +19% | +$25.2M |
|
91
Vertex Pharmaceuticals
VRTX
$121B
| $150M | 0.1% |
829,359
+37,531
| +5% | +$7.33M |
|
92
Walt Disney
DIS
$167B
| $148M | 0.1% |
875,492
-143,236
| -14% | -$25.5M |
|
93
Thermo Fisher Scientific
TMO
$213B
| $147M | 0.1% |
257,054
+112,157
| +77% | +$61.6M |
|
94
Chevron
CVX
$392B
| $143M | 0.09% |
1,409,605
+276,313
| +24% | +$27.6M |
|
95
Performance Food Group
PFGC
$18B
| $138M | 0.09% |
2,969,869
+307,199
| +12% | +$14.1M |
|
96
Avantor
AVTR
$9.32B
| $136M | 0.09% |
3,336,521
-638,271
| -16% | -$24.9M |
|
97
Labcorp
LH
$25B
| $132M | 0.09% |
544,534
-11,765
| -2% | -$2.96M |
|
98
Lam Research
LRCX
$367B
| $130M | 0.08% |
2,277,910
+278,510
| +14% | +$16.9M |
|
|
PDCE
99
DELISTED
PDC Energy, Inc.
PDCE
| $130M | 0.08% |
2,735,218
-195,534
| -7% | -$8.15M |
|
100
Teladoc Health
TDOC
$1.22B
| $128M | 0.08% |
1,008,967
+64,946
| +7% | +$9.46M |
|
Similar funds
Jennison Associates's Q3 2021 Portfolio in Review
As of Q3 2021, Jennison Associates held 761 positions worth $155B, up 2.5% from $151B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jennison Associates's Q3 2021 filing shows 96 new, 254 increased, 288 reduced and 100 closed positions. Its largest new stake was ZoomInfo Technologies: 3,206,107 shares worth $196M. The largest sale was Match Group, an estimated $929M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2021 buy was ZoomInfo Technologies: 3,206,107 shares worth $196M.
- Jennison Associates added most to BioNTech in Q3 2021, an estimated $1.21B increase.
- Jennison Associates's biggest Q3 2021 reduction was Match Group, cutting an estimated $929M.
- Jennison Associates fully exited Zoom in Q3 2021, selling an estimated $285M.
- Jennison Associates's ten largest holdings make up 38% of its $155B portfolio in Q3 2021.
- Jennison Associates opened 96 new positions and closed 100 in Q3 2021.
- Jennison Associates's portfolio value rose 2.5% quarter-over-quarter to $155B.
Based on Jennison Associates's 13F filing for Q3 2021, filed 9 Nov 2021.